Lupin Limited
Search results
Sep 25, 2024 · 1st company globally to commercialize interchangeable bGlargine in U.S. 2024. 1st company to get U.S. FDA approval for interchangeable bAflibercept. At Biocon Biologics, we are driven by a humanitarian purpose to make healthcare affordable and accessible to even the poorest of patients.
6 days ago · Biocon is an innovation led fully integrated biopharmaceutical company that develop affordable biosimilars, generic formulations & complex APIs.
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. [ 4 ] . The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, [ 5 ] including the United States and Europe. [ 4 ] .
Biocon Biologics is today one of the frontrunners in the global biosimilars industry, working to provide patients access to affordable biologics and enable health equity worldwide. Driven by a Purpose to Address Unmet Needs for Affordable Biologics.
Working with one of the world’s most advanced biopharmaceutical companies brings with it a tremendous opportunity to create a lasting impact on global health. It’s a chance to work alongside some of the brightest minds in research, healthcare, pharmaceutical, biotechnology and business sectors.
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and...
Biocon Biologics Limited (BBL) is a subsidiary of the publicly listed Biocon Limited, which operates its biosimilars business through BBL. Please refer to the Investors’ Section of Biocon Limited for all statutory information.
Dec 18, 2023 · Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced the successful completion of the transition of the acquired biosimilars business in ~120 countries across Advanced and Emerging Markets, a year ahead of schedule.
Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global...
A global biopharmaceutical company changing patients’ lives by finding new & affordable ways to treat diabetes, cancer & autoimmune diseases.
